ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
10
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,107
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Letter to FDA expressing concerns about the pending approval of the cancer drug gefitinib (IRESSA) (HRG Publication # 1665
Author(s):
Publication date:
2003
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cancer Metabolism
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
4,107
In-flight refocusing and MTF assessment of SPOT5 HRG and HRS cameras
Authors:
D. LEGER
,
F. Viallefont
,
E. Hillairet
…
Mapeo de índice de área foliar y cobertura arbórea mediante fotografía hemisférica y datos SPOT HRG: Regresión y k-nn
Authors:
C.A. Aguirre S.
,
J.R. Valdez L.
,
G. Angeles P
…
A comparative study of Terra ASTER, Landsat TM, and SPOT HRG data for land cover classification in the Brazilian Amazon
Authors:
See all similar
Cited by
1
Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures
Authors:
Tsutomu Nishimura
,
Harue Tada
,
Masatsugu Nakagawa
…
See all cited by